Background/Aims: Motility is a feature of many pathogens that contributes to the migration and dispersion of the infectious agent. Whether gentamycin has a post-antibiotic effect (PAE) on the swarming and swimming motility of Escherichia coli (E. coli) remains unknown. In this study, we aimed to examine whether short-term pretreatment of sub-inhibitory concentrations of gentamycin alter motility of E. coli and the mechanisms involved therein. Methods: After exposure to sub-inhibitory concentrations (0.8 μg/ml) of gentamicin, the swarming and swimming motility of E. coli was tested in semi-solid media. Real-time PCR was used to detect the gene expression of succinate dehydrogenase (SDH). The production of SDH and fumarate by E. coli pretreated with or without gentamycin was measured. Fumarate was added to swarming agar to determine whether fumarate could restore the swarming motility of E. coli. Results: After pretreatment of E. coli with sub-inhibitory concentrations of gentamycin, swarming motility was repressed in the absence of growth inhibition. The expression of all four subunits of SDH was down-regulated, and the intracellular concentration of SDH and fumarate, produced by E. coli, were both decreased. Supplementary fumarate could restore the swarming motility inhibited by gentamycin. A selective inhibitor of SDH (propanedioic acid) could strongly repress the swarming motility. Conclusion: Sub-inhibitory concentrations Y. Zhuang and W. Chen contributed equally to this work.
Introduction
Aminoglycosides are commonly used in clinical infections for their excellent effect against the gram-negative bacteria [1] . E. coli is one of the clinical pathogens that is included in the antibacterial spectrum of aminoglycosides [2] . It is also a leading pathogen that causes infections in the urinary tract and intestines [3] [4] [5] [6] . Motility is one of the pathogenic phenotypes of E. coli, contributing to the migration and dispersion of bacteria and escape from the host immune response [7] . Swarming is a bacterial phenomenon involving migration of bacteria on viscous substrates, and has been observed for a variety of motile bacteria [8] . In order to swarm, cells must differentiate into a specialized state (swarm cells) characterized by an increase in flagellum number and cell elongation, followed by movement as multicellular rafts across the surface. This is in contrast to swimming motility, which represents individual cell motility in an aqueous environment [9] .
Aminoglycosides have been reported to have a post-antibiotic effect (PAE) on many pathogen species [10] [11] [12] [13] . A previous study reported that the swarming motility of Serratia marcescens is inhibited by a 0.5-hour pretreatment of gentamycin or netilmycin [14] . However, whether gentamycin has a PAE on swarming and swimming motility of E. coli is still unclear. In this study, we characterized the motility of E. coli after treatment with gentamycin at sub-growth inhibitory concentrations.
According to Inoue et al. [8] , bacteria having mutations in the sdhA, sdhB or sdhC genes, which encode the subunits of succinate dehydrogenase (SDH), display swarming defects, but normal swimming motility. We hypothesized that repression of SDH gene expression might be the possible mechanism by which gentamycin inhibited swarming motility. To test this hypothesis, real-time PCR was used to identify gene expression changes of SDH, and the production of SDH by E. coli pretreated with or without gentamycin was measured. Quantification of fumarate, the enzymatic product of SDH, was also determined, and the effect of fumarate and a competitive succinate dehydrogenase inhibitor, on the swarming motility of E. coli after exposure to gentamycin, was also characterized.
Material and Methods
Bacteria and agents E.coli (ATCC 25922) used in this study was obtained from the Clinical Microbiology Laboratory of the First Affiliated Hospital of Shantou University Medical College (Shantou, China). Gentamycin was purchased from Sangon Biotech (CAS: 1405-41-0). Propanedioic acid (CAS: 141-82-2) and fumaric acid (CAS: 110-17-8) were purchased from MACLIN.
Determination of MIC (minimum inhibitory concentration) of gentamycin
The MIC of gentamycin was determined using the broth microdilution method recommended by CLSI 2009. Overnight cultures were grown in Mueller Hinton broth (MHB, OXOID, Lot: 1460487) at 37 o C and diluted to yield an inoculum of approximately 1×10
8 CFU (colony-forming units)/ml. Then 50 μl gentamycin (0.5-128 μg/ml) was dispensed into each well of a microtiter plate, and 50 μl of a 10 5 CFU/ml bacteria suspension was added to each well. The plate was incubated at 37 o C for 24h [15] . MIC was identified as the lowest concentration of gentamycin at which visible growth was inhibited. Each experiment was replicated 3 times.
Growth curve after pretreatment of a sub-inhibitory concentration of gentamycin
An overnight cultures of E. coli was diluted 1:20 in MHB containing 1/2 MIC (0.8 μg/ml) of gentamycin, then incubated at 37 o C for an hour. The cultures were centrifuged at 10,000 rpm for 3 min, then pellets were washed 3 times with fresh media, and then suspended in MHB. Each culture were diluted to a final OD 600 of 0.2 prior to addition into the wells. At the same time, the non-pretreated cultures were also spun down and resuspended as described above. A spectrophotometer (BIO-RAD) was used to read turbidity at 600 nm in order to monitor the growth. Readings were taken every 30 min for 22 hours by a microplate reader (Molecular Devices, SpectraMax M2e). Each experiment was done in triplicate.
Swarming and swimming motility assays
The media used for the swarming assay was 0.8% Luria-Bertani (LB) medium (OXOID) containing 0.5% (wt/vol) glucose (AMRESCO, Lot: 1103C188) and 0.6% (wt/vol) agar (OXOID, Lot: 12-64045-02). The media used for the swimming assay was 1% tryptone broth (OXOID, Lot: 1465651) containing 0.5% NaCl and 0.3% agar [16] . An overnight cultures of E. coli was diluted 1:20 in MHB in the presence of 1/2 MIC, 1/4 MIC or 1/8 MIC of gentamycin, or without gentamycin. The cultures were then incubated at 37 o C for an hour, then pelleted, washed, and then suspended and diluted in MHB to a final OD 600 of 0.2, and grown overnight as described above. Then 2 μl of bacterial cultures was spotted on the swarm and swim agar plates. The plates were incubated for 10 h at 37 o C. Swarm plates were then incubated an additional 24 h at room temperature for a total of 34 h [8, 16] . All swarm or swim agar plates were poured from the same batch of prepared agar to minimize variation in agar concentrations.
Real-time PCR
An overnight cultures of E. coli was diluted 1:20 inoculated in MH medium either with or without 1/2 MIC gentamycin, then incubated at 37 o C for an hour. Cultures were centrifuged at 10,000 rpm for 3 min and pellets were washed 3 times with fresh media in order to remove the gentamycin. Total RNA was isolated using an RNeasy Protect Mini Kit (Qiagen, Hilden, Germany, Cat: 74134) according to the manufacturer's instructions [17] . The integrity, purity and concentration of the extracted RNA templates were assessed with a Nanodrop (Thermal Scientific, ND2000) and agarose gel (1.5%) electrophoresis, then 1 μg total RNA was converted to cDNA (TAKARA, Dalian, China, Cat: RR047A) by reverse transcription. For real-time PCR quantification, 1μl cDNA was amplified (TAKARA, Cat: RR820A) using an Eco™ Real-Time PCR System (Illumina). The GAPDH gene was used as the housekeeping reference gene [18] . The primers used in realtime PCR quantification of expression of each gene are listed in Table 1 . The fold change was calculated using the 2ΔΔCt method presented as the fold change in expression of pretreatment groups relative to the control group (no drug treatment). [19] Quantification of SDH For quantitation of SDH, an overnight cultures of E. coli was prepared as for RT-PCR except that washed bacterial pellets were resuspended in 100 μl of phosphate-buffered saline (PBS). An ultrasonic cell disrupter was used to disrupt cells (200W, 5 times, 30 seconds each time with an interval of 30 seconds). An enzyme linked immunosorbent assay (ELISA, Shanghai Future Industrial Limited by Share Ltd, Cat: JL-Y0858) was used to measure SDH levels in 10 μl of sample according to the manufacturer's instructions. Absorbance was measured at 450 nm using a microplate reader. Standards of 30 μmol/l, 20 μmol/l, 10 μmol/l, 5.0 μmol/l, and 2.5 μmol/l SDH were added to each well, and a linear standard curve was generated. Quantification of fumarate Quantification of fumarate was performed using a Fumarate Assay Kit (Sigma-Aldrich, USA, Cat: MAK060). Briefly, an overnight cultures of E. coli were diluted 1:20 in MHB with or without 1/2 MIC gentamycin, then incubated at 37 o C for one hour. An aliquot of 100 μl of each culture was then centrifuged at 10,000 rpm for 3 min. Pellets were washed 3 times with fresh media and suspended in 100 μl of fumarate assay buffer. An ultrasonic cell disrupter was used to disrupt cells (200W, 5 times, 10 seconds each time with an interval of 10 seconds), then 50 μl of each sample was added into duplicate wells of a 96-well plate. Master reaction mix (100 μl) was added to each of the wells, and the plate was shaken on a horizontal shaker, and incubated for 60 minutes at 37 o C. The absorbance of each well was measured at 450 nm (A450) by a microplate reader. Fumarate standards with 0 (blank), 2, 4, 6, 8 and 10 nmole/well were added into each well, and a linear standard curve was generated for quantification of fumarate.
Regulation of swarming motility by fumarate
The MICs of propanedioic acid and fumaric acid were determined, for E. coli ATCC 25922, using polystyrene 96-well plate. An overnight cultures were grown in MHB at 
Statistical analysis
Differences among groups were tested by one-way ANOVA. P < 0.05 was considered statistically significant.
Results

Determination of MIC and sub-inhibitory concentrations of gentamycin
The MIC of gentamycin against E. coli ATCC25922 was 1.6 μg/ml. After exposure to 1/2 MIC (0.8 μg/ml) gentamycin for an hour, the pretreated strain had the very similar growth curve as the untreated control (Fig. 1) . Consequently, 1/2 MIC gentamycin pretreatment did not affect the growth of E. coli. Fig. 1 . Growth curve of E. coli ATCC25922 after a 1 hour-exposure to 1/2 MIC gentamycin. After exposure to 1/2 MIC (0.8 μg/ml) gentamycin, the pretreated strain had the very similar growth curve as the control (no pretreatment). These results show that 1/2 MIC gentamycin pretreatment did not significantly affect the growth of E. coli.
Gentamycin pretreatment inhibits swarming, but not swimming motility of E. coli
The swimming motility and the swarming motility of E. coli ATCC25922 were observed on the agar. Pretreatment for 1 h with 1/2 (0.8 μg/ml), 1/4 (0.4 μg/ml) and 1/8 (0.2 μg/ ml) MIC of gentamycin are no significant in swimming motility of E. coli (Fig. 2B and Table  2 ). However, the same concentrations of gentamycin were all able to inhibit the swarming motility of E. coli ( Fig. 2A and Table 2 ). Furthermore, the degree of inhibition of swarming motility was directly proportional to the concentration of gentamycin.
Succinate dehydrogenase expression is down-regulated by sub-inhibitory concentrations of gentamycin
Real-time PCR was performed to determine whether a sub-inhibitory concentration of gentamycin suppresses the expression of succinate dehydrogenase subunit genes. As shown in Figure 3A , pretreatment with 1/2 MIC gentamycin, the expression of four succinate dehydrogenase subunit genes sdhA, sdhB, sdhC and sdhD was down-regulated 3 to 4-fold (P<0.05). To confirm the down-regulation of SDH expression, an ELISA was used to determine SDH protein concentration following pretreatment with sub-inhibitory concentrations of gentamycin. The results (Fig. 3B) showed that after pretreatment with 1/2 MIC (0.8 μg/ml) gentamycin, the concentration of intracellular SDH of E. coli ATCC25922 was reduced from 3.09 to 1.30 μmol/l (P<0.05). This suggests that synthesis of SDH is decreased following pretreatment with 0.8 μg/ml gentamycin, and that this inhibition is independent of growth inhibition. Figure 3C shows the intracellular fumarate concentration of E. coli pretreated with 0.8 µg/ml gentamycin. The concentration of intracellular fumarate of E. coli was reduced from 78.4 to 50.8 μmol/L (P<0.05). Pretreatment with gentamycin resulted in significantly Fig. 4 . Swarming motility of E. coli pretreated with gentamycin is restored by fumarate. a. control (no treatment); b. pretreated with 1/2 MIC gentamycin; c. pretreated with 1/2 MIC gentamycin, 0.9 mM fumarate was contained in agar plate; d. pretreated with 1/2 MIC gentamycin, 1.8 mM fumarate was contained in agar; e. pretreated with 1/2 MIC gentamycin, 3.6 mM fumarate was contained in agar; f. no pretreatment with gentamycin, 1.8 mM fumarate was contained in agar; g. no pretreatment with gentamycin, 2 mM propanedioic acid was contained in agar; h. pretreated with 1/2 MIC gentamycin, 2 mM propanedioic acid was contained in agar.
Gentamycin pretreatment inhibits swarming motility in a fumarate-dependent manner
less fumarate production compared to the control.To determine whether the gentamycinmediated inhibition of swarming was due to a reduction in fumarate content, we characterized the effects of propanedioic acid, an SDH inhibitor, and fumarate on the swarming ability of E. coli. The MICs of propanedioic acid and fumarate against E. coli were 18 mM and 20 mM. Figure 4 and Table 3 showed that pretreated with 1/2 MIC gentamycin is able to inhibit the swarming motility of E. coli ( a vs b). Fumarate significantly reversed this gentamycinmediated inhibition of swarming motility and the degree of reversed was proportional to the concentration of fumarate (b-e). Fumarate also promoted the motility of untreated E. coli (a vs f). Propanedioic acid significantly suppresses swarming, regardless of whether or not E. coli were pretreated with gentamycin (a vs g, b vs h).
Discussion
The effects of gentamycin on the motility of bacteria have previously been described [14, 21] , and the length of the PAE varies with the duration of exposure to the antibiotic and its concentration [14, 22] . However, the mechanisms by which bacterial motility is inhibited remain unclear. In the present study, we examined whether a short-term pretreatment of sub-inhibitory concentrations of gentamycin would affect E. coli motility, and investigated the mechanisms involved. We initially demonstrated that pretreatment of E. coli with 1/2 MIC gentamycin did not significantly affect the growth or swimming motility of E. coli, but did suppress swarming motility. Furthermore, the degree of inhibition of swarming motility was directly proportionated to the concentration of the gentamycin (Fig. 2) . Therefore, a one-hour exposure to sub-inhibitory concentrations of gentamycin influences the motility of E. coli independent of a bacteriostatic action. We consider this effect to be a PAE of gentamycin, although bacterial growth is unaffected. Swarming and swimming are quite different. Swarming cells move as multicellular rafts, whereas swimming motility in aqueous environments involves movement as single cells [8, 23] . Swarming motility is a factor that prompts the migration and dispersion of bacteria in infected patients. Therefore, our demonstration that sub-inhibitory concentrations of gentamycin inhibit swarming motility suggests that it has the advantage in treating E. coli-infected patients.
SDH catalyzes the oxidation of succinate to fumarate and donates electrons to ubiquinone of the aerobic respiratory chain. It is unique in the TCA cycle as the only membrane-bound enzyme [24, 25] . SDH is encoded by sdhCDAB gene cluster. Two membrane embedded polypeptides, encoded by sdhC and sdhD, interact with ubiquinone, and the remaining sdhA and sdhB genes encode the flavoprotein and the iron-sulfur protein respectively [26] [27] [28] [29] . It has been reported that the swarming motility, of sdhA, sdhB and sdhC mutant strains, is strongly repressed, while swimming is not significantly inhibited [8] . Because of the similarity in the behavior of our gentamycin-treated bacteria and mutant SDH bacteria, in order to investigate the underlying mechanisms that contribute to the gentamycin-inhibited Table 3 . Mean ± SD of colony diameter (mm) of swarming motility. Swarming motility E. coli pretreated by gentamycin was restored by fumarate. a. control (no treatment); b. pretreated with 1/2 MIC gentamycin; c. pretreated with 1/2 MIC gentamycin, 0.9 mM fumarate was contained in agar plate; d. pretreated with 1/2 MIC gentamycin, 1.8 mM fumarate was contained in agar; e. pretreated with 1/2 MIC gentamycin, 3.6 mM fumarate was contained in agar; f. no pretreatment with gentamycin, 1.8 mM fumarate was contained in agar; g. no pretreatment with gentamycin, 2 mM propanedioic acid was contained in agar; h. pretreated with 1/2 MIC gentamycin, 2 mM propanedioic acid was contained in agar. *P<0.05 vs. a; # P<0.05 vs b swarming motility of E. coli, we detected the expression of sdh genes and the cellular level of SDH in gentamycin-treated E. coli. Real-time PCR showed that after being pretreated with 1/2 MIC gentamycin, the mRNAs for all four subunits of SDH were down-regulated (Fig. 3A) , and the protein concentration of SDH decreased similarly following gentamycin pretreatment (Fig. 3B) . These results indicate that pretreatment with sub-inhibitory concentrations of gentamycin significantly reduce the cellular synthesis of SDH through down-regulating the encoding genes. Previous experiments have reported that fumarate plays an important role in swarming of bacteria. Alteri et al. demonstrated the swarming ability of sdhB mutant P. mirabilis could be restored after adding fumarate [30] , and Tan et al. indicated that the addition of fumarate induces swarming motility [31] . Since fumarate is formed by the oxidation of succinate by SDH, we speculate that the decreased level of SDH also leads to reduced production of fumarate, and this consequently causes the inhibition of E. coli swarming. We then detected the production of fumarate in E. coli pretreated with or without 1/2 MIC gentamycin and found that fumarate produced by gentamycin-pretreated E. coli is also decreased (Fig. 3C) . Fumarate was then added into swarming agar to determine whether swarming motility, inhibited by pretreated with gentamycin, could be restored. As expected, the supplementary fumarate in agar could restore the swarming motility inhibited by pretreatment of gentamycin, and the degree of restoration was directly proportional to the concentration of added fumarate (Fig. 4) . Conversely, propanedioic acid, a selective inhibitor of SDH which is able to decrease the fumarate production, strongly represses swarming, regardless of whether or not E. coli were pretreated with gentamycin (Fig. 4) . These results confirm the intimate connection between fumarate and swarming motility, and furthermore, suggest that pretreatment with gentamycin reduces the synthesis of fumarate by E. coli via the down-regulation of sdh genes to cause the suppressed swarming motility.
It has been suggested that swarming is a more energy-consuming process than swimming [8] , and the tricarboxylic acid (TCA) cycle is the source of energy for bacterial swarming motility [32] . Alteri et al. also indicate that the addition of fumarate does not restore swarming in fumarase mutant strains [30] , indicating that fumarate acts as a swarming stimulus by taking part in the TCA cycle to provide energy. However, Inoue et al. reported that the total activity of the TCA cycle is not necessary for swarming in E. coli [8] . Furthermore, Kim et al. also found that there is no significant difference in the intracellular ATP levels between swarmers and swimmers of S.enterics serovar Typhimurium 14028 (ATCC 14028) [32] . These studies suggest that swarming is not a more ATP-consuming behavior than swimming, and fumarate may induce swarming motility via a TCA-independent pathway. Whether fumarate promotes swarming by direct stimulation, or indirectly by interfering with the metabolic processes still requires further study.
Numerous studies have shown that swarming is an adaption that leads to the multiple antibiotic resistance phenotypes and increased production of virulence factors for many bacteria [33, 34] . Therefore, the inhibition of swarming motility by gentamycin could be beneficial in controlling the virulence and resistance of E. coli to antibiotics.
Taken together, we demonstrate that sub-inhibitory concentrations of gentamycin inhibit the swarming motility of E. coli. This effect is mediated by down-regulation of SDH, followed by reduced intracellular fumarate levels. This PAE of gentamycin suggests that gentamycin may be advantageous in blocking E. coli migration in E. coli-infected patients.
